# Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome

> **NCT00955994** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 100 (—)

## Conditions studied

- Irritable Bowel Syndrome

## Interventions

- **DRUG:** asimadoline

## Key facts

- **NCT ID:** NCT00955994
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 100 (—)
- **Last updated:** 2011-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00955994

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00955994, "Effect of Asimadoline, a Member of a New Medication Class, on Acute Attacks of Pain in Irritable Bowel Syndrome". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00955994. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*